Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters - A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Berger, William T ^a   Ralph, Brian P ^a   Kaczocha, Martin ^a   Sun, Jing ^a   Balius, Trent E ^b   Rizzo, Robert C ^b   Haj Dahmane, Samir ^c   Ojima, Iwao ^a   Deutsch, Dale G ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

^c RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TRUXILLIC ACID 1 NAPHTHYL MONOESTER; ANANDAMIDE; ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; BMS 309403; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; GAMMA TRUXILLIC ACID 1 NAPHTHYL MONOESTER; HERBACEOUS AGENT; INCARVILLATEINE; OLEIC ACID; PROTEIN FABP5; PROTEIN FABP7; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; BINDING ASSAY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG DESIGN; DRUG IDENTIFICATION; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ANALYSIS;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACIDS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DRUG DISCOVERY; ENDOCANNABINOIDS; FATTY ACID-BINDING PROTEINS; HUMANS; MICE; POLYUNSATURATED ALKAMIDES; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; INCARVILLEA SINENSIS; MUS;

EID: 84870938235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050968     Document Type: Article

References (31)

1. Furuhashi M, Hotamisligil GS, (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7: 489-503.
2. Kaczocha M, Glaser ST, Deutsch DG, (2009) Identification of intracellular carriers for the endocannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America 106: 6375-6380.
3. Howlett AC, Reggio PH, Childers SR, Hampson RE, Ulloa NM, et al. (2011) Endocannabinoid tone versus constitutive activity of cannabinoid receptors. Br J Pharmacol 163: 1329-1343.
4. Kaczocha M, Vicieca S, Sun J, Glaser ST, Deutsch DG, (2012) Fatty Acid-binding Proteins Transport N-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors. J Biol Chem 287: 3415-3424.
5. Ahn K, Johnson DS, Cravatt BF, (2009) Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert opinion on drug discovery 4: 763-784.
6. Veerkamp JH, Zimmerman AW, (2001) Fatty acid-binding proteins of nervous tissue. Journal of molecular neuroscience: MN 16: 133-142 discussion 151-137.
7. Barf T, Lehmann F, Hammer K, Haile S, Axen E, et al. (2009) N-Benzyl-indolo carboxylic acids:Design and synthesis of potent and selective adipocyte fatty-acid bind protein (A-FABP) inhibitors. Bioorg Med Chem Lett 19: 1745-1748.
8. Sulsky R, Magnin DR, Huang Y, Simpkins L, Taunk P, et al. (2007) Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg Med Chem Lett 17: 3511-3515.
9. DOCK6.5 (2011) San Francisco, CA: University of California at San Francisco.
10. Balius TE, Mukherjee S, Rizzo RC, (2011) Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons. J Comput Chem 32: 2273-2289.
11. Holden PM, Kaur H, Gochin M, Rizzo RC, (2012) Footprint-based identification of HIVgp41 inhibitors. Bioorg Med Chem Lett ss pp. 3011-3016.
12. Irwin JJ, Shoichet BK, (2005) ZINC- A Free Database of Commercially Available Compounds for Virtual Screening. J Chem Inf Model 45: 177-182.
13. Nakamura M, Chi YM, Yan WM, Nakasugi Y, Yoshizawa T, et al. (1999) Strong Antinociceptive Effect of Incarvillateine, a Novel Monoterpene Alkaloid from Incarvillea sinensis. J Nat Prod 62: 1293-1294.
14. Chi YM, Nakamura M, Yashizawa T, Zhao XY, Yan WM, et al. (2005) Anti-inflammatory activities of alpha-truxillic acid derivatives and there monomer components. Biol Pharm Bull 28: 1776-1778.
15. Chi YM, Nakamura M, Zhao XY, Yoshizawa T, Yan WM, et al. (2006) Antinociceptive activities of alpha-truxillic acid and beta-truxinic acid derivatives. Biol Pharm Bull 29: 580-584.
16. Haj-Dahmane S, Shen RY, (2009) Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors. The Journal of pharmacology and experimental therapeutics 331: 186-196.
17. Steri R, Rupp M, Proschak E, Schroeter T, Zettl H, et al. (2010) Truxillic acid derivatives act as peroxisome proliferator-activated receptor gamma activators. Bioorg Med Chem Lett 20: 2920-2923.
18. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, et al. (2006) Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319: 1051-1061.
19. Churi SB, Abdel-Aleem OS, Tumber KK, Scuderi-Porter H, Taylor BK, (2008) Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. J Pain 9: 639-649.
20. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, et al. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America 98: 9371-9376.
21. Lichtman AH, Martin BR, (1990) Spinal action of cannabinoid-induced antinociception. NIDA Res Monogr 105: 422-424.
22. Cravatt BF, Lichtman AH, (2004) The endogenous cannabinoid system and its role in nociceptive behavior. Journal of neurobiology 61: 149-160.
23. Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, et al. (2011) A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nature neuroscience 15: 64-69.
24. Maccarrone M, Dainese E, Oddi S, (2010) Intracellular trafficking of anandamide: new concepts for signaling. Trends in Biochemical Sciences 35: 601-608.
25. Fowler CJ, (2012) Anandamide uptake explained? Trends Pharmacol Sci 33: 181-185.
26. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Femin TE, (1982) A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology 161: 269-288.
27. Mukherjee S, Balius TE, Rizzo RC, (2010) Docking Validation Resources: Protein Family and LIgand Flexibility Experiments. Journal of Chemical Information and Modeling 50: 1986-2000.
28. Hunter JD, (2007) Matplotlib: A 2D Graphics Environment. Computing in Science & Engineering 9: 90-95.
29. Yang H, Jia L, Wang Z, Di-Cicco A, Levy D, et al. (2011) Novel Photolabile Diblock Copolymers Bearing Truxillic Acid Derivative Junctions. Macromolecules pp. 159-165.
30. Arendaruk SA, Kharkevich DA, (1967) Studies on Cyclobutanedicarboxylic Acids V. Sythesis of Bisquarternary Salts of Alkylamine Esters and Amides of the Stereoisomeric Truxillic Acids. Khimiko-Farmatsevticheskii Zhurnal pp. 18-21.
31. Haj-Dahmane S, Shen RY, (2005) The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J Neurosci 25: 896-905.